Discovery and Preclinical Pharmacology of Capecitabine

作者: Hideo Ishitsuka

DOI: 10.1007/978-1-59259-337-8_20

关键词: Adverse effectCancerOral administrationCytotoxic T cellDrugToxicityPharmacologyBone marrowIntestinal mucosaMedicine

摘要: Cytotoxic drugs have been widely used for the treatment of cancer and will continue to play a major role in chemotherapy at least throughout next decade. However, efficacy cytotoxic is still far from satisfactory many types malignant diseases as they generally lack tumor selective activity. They act not only on cells but also rapidly growing normal cells, such granulocyte progenitor bone marrow cryptic intestinal mucosa, resulting adverse events these tissues. Consequently, could be prescribed frequently long periods or dose level sufficiently high cure cancer. Bone toxicity, whcih often results opportunistic infections thus limits use particularly outpatients, most common problem with drugs. Intestinal toxicity another event drugs, when are given orally. Oral administration leads local drug concentrations predominantly sites, intestine liver, treatment-associated effects organs. In addition, oral doses general larger than parenteral ones, because orally subjected first-pass metabolic tract liver. Dose reduction spare organ would result insufficient compared that administration.

参考文章(36)
Gerald W. Camiener, Charles G. Smith, Studies of the enzymatic deamination of cytosine arabinoside—I: Enzyme distribution and species specificity Biochemical Pharmacology. ,vol. 14, pp. 1405- 1416 ,(1967) , 10.1016/0006-2952(65)90175-9
Hideo Ishitsuka, Hiromi B. Maruyama, Keiko Fukuoka, Kenji Takemoto, Masanori Miwa, Akemi Itoga, Role of uridine phosphorylase for antitumor activity of 5'-deoxy- -5-fluorouridine. GANN Japanese Journal of Cancer Research. ,vol. 71, pp. 112- 123 ,(1980) , 10.20772/CANCERSCI1959.71.1_112
AKIRA KONO, YASUHIRO HARA, SETSURO SUGATA, YOSHIHARU KARUBE, YOSHIKAZU MATSUSHIMA, HIDEO ISHITSUKA, Activation of 5'-Deoxy-5-fluorouridine by Thymidine Phosphorylase in Human Tumors Chemical & Pharmaceutical Bulletin. ,vol. 31, pp. 175- 178 ,(1983) , 10.1248/CPB.31.175
Hiroyasu Baba, Takuma Sasaki, Kazuo Nitta, Mieko Takeuchi, Tomiko Tanaka, Nobuaki Uehara, Takehiko Kunimoto, The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors. Japanese Journal of Cancer Research. ,vol. 76, pp. 1034- 1041 ,(1985) , 10.20772/CANCERSCI1985.76.10_1034
M Mackean, A Planting, C Twelves, J Schellens, D Allman, B Osterwalder, B Reigner, T Griffin, S Kaye, J Verweij, Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer. Journal of Clinical Oncology. ,vol. 16, pp. 2977- 2985 ,(1998) , 10.1200/JCO.1998.16.9.2977
M C Etienne, S Chéradame, J L Fischel, P Formento, O Dassonville, N Renée, M Schneider, A Thyss, F Demard, G Milano, Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. Journal of Clinical Oncology. ,vol. 13, pp. 1663- 1670 ,(1995) , 10.1200/JCO.1995.13.7.1663
G Liu, E Franssen, M I Fitch, E Warner, Patient preferences for oral versus intravenous palliative chemotherapy. Journal of Clinical Oncology. ,vol. 15, pp. 110- 115 ,(1997) , 10.1200/JCO.1997.15.1.110
Eric Van Cutsem, Michael Findlay, Bruno Osterwalder, Walter Kocha, David Dalley, Richard Pazdur, Jim Cassidy, Luc Dirix, Chris Twelves, David Allman, Jean-Francois Seitz, Jürgen Schölmerich, Hans Ulrich Burger, Jaap Verweij, Capecitabine, an Oral Fluoropyrimidine Carbamate With Substantial Activity in Advanced Colorectal Cancer: Results of a Randomized Phase II Study Journal of Clinical Oncology. ,vol. 18, pp. 1337- 1345 ,(2000) , 10.1200/JCO.2000.18.6.1337
Joanne L. Blum, Stephen E. Jones, Aman U. Buzdar, Patricia Mucci LoRusso, Irene Kuter, Charles Vogel, Bruno Osterwalder, Hans-Ulrich Burger, Cheryl Stoner Brown, Tom Griffin, Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer Journal of Clinical Oncology. ,vol. 17, pp. 485- 493 ,(1999) , 10.1200/JCO.1999.17.2.485
Bruce A. Chabner, David G. Johns, C. Norman Coleman, James C. Drake, Warren H. Evans, Purification and Properties of Cytidine Deaminase from Normal and Leukemic Granulocytes Journal of Clinical Investigation. ,vol. 53, pp. 922- 931 ,(1974) , 10.1172/JCI107633